Linked Life Data

16675570

Source:http://linkedlifedata.com/resource/pubmed/id/16675570

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2006-5-5
pubmed:abstractText
Overexpression of beta III tubulin has been involved in paclitaxel resistance in several experimental models. We investigated the role of beta III tubulin as predictor of clinical outcome in ovarian cancer patients given platinum/paclitaxel treatment. We also investigated whether beta III tubulin expression could be modified after the selective pressure represented by chemotherapy in vivo.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2774-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients.
pubmed:affiliation
Department of Oncology, Catholic University, Campobasso, Italy. gabriella.ferrandina@libero.it
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't